CADAS138 emerges as a novel therapeutic target in the realm of chronic illnesses. Preclinical studies demonstrate significant potential for CADAS138-targeted therapies to mitigate disease progression. Researchers are https://aishalbjk151713.mpeblog.com/72022527/a-potential-therapeutic-strategy